Association between nitric oxide and oxidative stress in continuous ambulatory peritoneal dialysis patients peritonitis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 6, 2007, Pages 654-660

  Duranay, M ^a   Yilmaz, F M ^a   Yilmaz, G ^a   Akay, H ^a   Parpucu, H ^a   Yucel D ^a  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Continuous ambulatory peritoneal dialysis; Malondialdehyde; Nitric oxide; Peritonitis

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; BIOLOGICAL MARKER; DIALYSIS FLUID; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; METABOLITE; OXIDATIVE STRESS; PERITONITIS; PRIORITY JOURNAL; BLOOD; CHEMISTRY; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; DIALYSIS SOLUTIONS; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 38749086548     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701253350     Document Type: Article

References (22)

1. Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, et al. Nitrate in stable CAPD patients and during peritonitis. Adv Perit Dial 1995;11:36-40.
2. Yang CW, Hwang TL, Wu CH, Lai PC, Huang JY, Yu CC, et al. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1996;11:2466-71.
3. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992;258:1898-902.
4. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
5. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002 Dec 1;33:1451-64.
6. Gawel S, Wardas M, Niedworok E, Wardas P. MDA as a lipid peroxidation marker. Wiad Lek 2004;57:453-5.
7. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316-28.
8. Buffone GJ, Lewis SA, Iosefsohn M, Hicks JM. Chemical and immunochemical measurement of total iron-binding capacity compared. Clin Chem 1978;24:1788-91.
9. Smarason AK, Allman KG, Young D, Redman CWG. Elevated levels of serum nitrate, a stable endproduct of nitric oxide, in women with preeclampsia. Br J Obstet Gynecol 1997;104:538-43.
10. Hunter MIS, Nlemadim BC, Davidson DLW. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluids from multiple sclerosis patients. Neurochem Res 1985;10:1645-52.
11. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. Br Med J 1994;309:453-7.
12. Plum J, Tabatabaei MM, Lordnejad MR, Pipinika O, Razeghi P, Huang C, et al. Nitric oxide production in peritoneal macrophages from peritoneal dialysis patients with bacterial peritonitis. Perit Dial Int 1999;19:378-83.
13. Davenport A, Fernando RL, Varghese Z. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Blood Purif 2004;22:216-23.
14. Davenport A, Fernando RL, Robson R, Varghese Z. Nitric oxide production by human peritoneal mesothelial cells. Int J Artif Organs 2004;27:15-23.
15. Marcinkiewicz J, Grabowska A, Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 1995;25:947-51.
16. Verger C, Luger A, Moore HL, Nolph KD. Acute changes in peritoneal transport properties with infectious peritonitis and mechanical injury. Kidney Int 1983;23:823-31.
17. Krediet RT, Zuyderhoudt MJ, Boeschoten EW, Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987;17:43-52.
18. Davies SJ, Bryan J, Phillips L, Russell GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996;11:498-506.
19. Ferrier ML, Combet S, van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, et al. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 2001;60:2343-50.
20. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of four hydroxynonenal malondialdehyde and related aldehydes. Free Radicals Biol Med 1991;62:81-128.
21. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high performance liquid chromatography. Anal Biochem 2002;311:76-9.
22. Teale DM, Atkinson AM. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992;30:839-42.